Saturday, June 13, 2009

LS9 Names Ed Dineen as Chief Executive Officer

LS9 Names Ed Dineen as Chief Executive Officer

Biotechnology company LS9, Inc. today announced the appointment of Edward J. Dineen as Chief Executive Officer and President

South San Francisco, CA (PRWEB) December 8, 2010

Biotechnology company LS9, Inc. today announced the appointment of Edward J. Dineen as Chief Executive Officer and President. Mr. Dineen will also become a member of the LS9 Board of Directors. He replaces Bill Haywood who has served as CEO of LS9 since September 2008.

“We thank Bill for his contributions to the company,” said Noubar Afeyan, Chairman of the LS9 Board of Directors and Managing Partner of Flagship Ventures. “We are pleased to welcome Ed to LS9 and have him lead the company moving forward. Ed’s experience and long track record of growing lines of business across many industries and geographic regions will help accelerate LS9’s growth and fully capitalize on the diverse product opportunities created by the company’s powerful technology platform. Ed shares our vision of making LS9 a world leader in renewable fuels and chemicals.”

Mr. Dineen was most recently the Chief Operating Officer of LyondellBasell Industries (NYSE:LYB), one of the world’s largest petrochemical, fuels and polymers companies with annual revenues of over $30 billion, sales in more than 100 countries, and 59 manufacturing sites in 18 countries on five continents. He was previously President of LyondellBasell’s chemicals division responsible for global chemical operations, sales and business management. Prior to the merger of Basell and Lyondell Chemical Company, Mr. Dineen was Senior Vice President, Chemicals and Polymers, and before that, Senior Vice President, Urethanes and Performance Chemicals. His career experiences include engineering, environmental health and safety, manufacturing, finance and strategic planning, supply chain, mergers and acquisitions, and business and sales management. In addition, Mr. Dineen is a member of the Board of Directors of Spartech (NYSE:SEH), a U. S.-based plastics company with headquarters in St. Louis.

“LS9 is an exciting company with outstanding technology and people and I look forward to building on this foundation,” said Mr. Dineen. “I see a clear path to significant revenue and profitability growth well into the future.”

About LS9
LS9, Inc. is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure, as well as high-value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. In June 2010, LS9 was awarded the U. S. Environmental Protection agency’s highest environmental honor for its revolutionary Renewable Petroleum™ technology. The company was founded in 2005 and Flagship Ventures, Khosla Ventures, Lightspeed Venture Partners and Chevron Technology Ventures, have provided funding to date. LS9 is headquartered in South San Francisco, California.